Dentsply (XRAY) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Dentsply
Is Dentsply a buy right now? The alternative data leans no. This XRAY stock analysis is built on the 25+ alternative data signals AltIndex tracks on Dentsply every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 34/100: a Sell. The stock trades at $12.26 with a $2B market cap.
The 90-day pressure points: web traffic down 18.9% to 472K monthly visits, business outlook fell 10.8% — now 33% of employees are positive, and job postings down 7.2% to 465 open roles. Stocks scoring below 40 have historically lagged the market.
XRAY’s broader alt-data profile also covers headcount (11K employees, according to LinkedIn), quarterly revenue ($880M), Facebook followers (602K), and sentiment (100/100). Every signal links to its own page with full history, the XRAY technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on XRAY is just below.
Dentsply AI Stock Analysis
Dentsply Sirona Inc. (NASDAQ: XRAY) is a global leader in the design, manufacture, and marketing of dental equipment and dental consumables. The company serves dental professionals and laboratories worldwide, providing a comprehensive offer that includes dental implants, endodontics products, and orthodontic supplies.
Analysis generated July 1, 2026.
Recent Dentsply Stock Alerts
|
Dentsply | July 6 Price is up by 6% in the last 24h. |
|
Dentsply | June 23 Business Outlook among employees is down by 5.7% over the last month. |
|
Dentsply | June 18 Insider Alert: HOSEIN CLYDE is buying shares |
|
Dentsply | June 1 Job postings are down by 16.1% in the last couple of days. |
Dentsply Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 472K | 18.9% | |
| Job Posts | 465 | 7.2% | |
| LinkedIn Employees | 11K | 0.5% | |
| Employee Recommend | 51 | 8.9% | |
| Business Outlook | 33 | 10.8% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 4 | 76.5% | |
| Stocktwits Mentions | 4 | 100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 1K | 3.6% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 12K | 0% | |
| Instagram Followers | 35K | 2.7% | |
| Facebook Followers | 602K | 0% | |
| Facebook Engagement | 9 | 350.0% |
About Dentsply (XRAY)
Dentsply Sirona Inc is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. It also manufactures and markets other consumable medical device products.
| Price | $12.26 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $2B |
| Year Range | $10 – $16 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical & Dental Instruments |
Latest Dentsply News
View more →
DENTSPLY SIRONA Inc. (XRAY)’s Shares Are Flat Since Cramer Commented On ThemJuly 7 - Yahoo Entertainment |
|
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital DentistryJuly 1 - GlobeNewswire |
|
 |
How DENTSPLY SIRONA’s New Veteran CFO Could Shape Capital Allocation and Strategy for XRAY InvestorsJune 14 - Biztoc.com |
 |
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?June 5 - PRNewswire |
Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional MarketsMay 26 - GlobeNewswire |
|
Dentsply Earnings & Financial Performance
View all earnings →Dentsply Insider Trading Activity
View all →| Gladden Brian T filed to sell 61,849 shares at $0.0. Jun 15 '26 |
| HOSEIN CLYDE filed to sell 70,575 shares at $0.0. Jun 15 '26 |
| MCKEON BRIAN P filed to sell 10,000 shares at $0.0. Jun 12 '26 |
| Barber Michael J filed to sell 55,943 shares at $0.0. Jun 11 '26 |
| HOLDEN BETSY D filed to sell 87,528 shares at $0.0. Jun 11 '26 |
Dentsply Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gil Cisneros |
Feb 12, 25 | Sell | $8K+ |
| Gil Cisneros |
Feb 12, 25 | Sell | $8K+ |
| Rohit Khanna |
Nov 8, 23 | Buy | $8K+ |
| Rohit Khanna |
Dec 6, 22 | Sell | $8K+ |
| Rohit Khanna |
Jun 10, 22 | Buy | $8K+ |
Stocks Similar to Dentsply
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
LeMaitre VascularLMAT |
$102.74 0.3% | $2B | 49 |
 |
NeogenNEOG |
$9.62 1.3% | $2B | 50 |
 |
NovoCureNVCR |
$16.30 5.7% | $2B | 47 |
 |
AtricureATRC |
$34.28 0.8% | $2B | 58 |
 |
iRhythm TechnologiesIRTC |
$116.13 1.5% | $4B | 46 |
Explore Dentsply Data
Frequently Asked Questions: Dentsply (XRAY)
Dentsply has an AltIndex AI Score of 34/100 (Sell). The score reflects negative alternative data signals. All investments carry risk.
34/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Dentsply (XRAY) stock is $12.26 with a market cap of $2B.
As of today, Dentsply’s PE (Price to Earnings) ratio is —.
View the latest Dentsply insider transactions to see recent buying and selling activity by company executives and directors.
Check the Dentsply congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The XRAY stock price chart above shows Dentsply’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Dentsply technical analysis for RSI, moving averages, and more.
See the stocks similar to Dentsply section on this page for companies in the same industry ranked by market cap and AI Score.
